Akihiro Furukawa

Yaklaşan katılımlar

• 8th CNS Drug Delivery Summit

  1–3 Dec 2026Boston, United States of America

  • PanelPanel Discussion: The Investment Landscape for CNS Delivery Technologies: Trends, Drivers & Funding Prioritiesİle: Lipa Shah, Miles Gerson, Hugh Nuthall, Andrew Steinsapir, Ross Jeggo

Geçmiş katılımlar

• Oncology & Immunology Innovation Partnering & Licensing Summit

  9–10 Sept 2026Boston, United States of America

  • PanelPharma Icebreaker Panel Discussion: Targeted Oncology Biologicsİle: Michael Torres, Carla Bauer, Matthew Posluszny, Anu Connor, Hong Xin, Juanjo Cragnolini, Xiaodong Zhang, Ayano Takeuchi

Şu etkinlikteki diğer konuşmacılar: 8th CNS Drug Delivery Summit

• Mathias Schmidt

  President & Chief Executive Officer, ArmaGen & JCR Pharmaceuticals

• Janelle Arrambide

  Head of Device Clinical, Biogen

• Susana Correia

  Director, Neuromuscular Research, Dyne Therapeutics

• Ajit D’Souza

  Executive Director, Drug Delivery & Devices DDCS, Eli Lilly

• Andrew East

  Head of IDU Device Development & Manufacturing, Biogen

• Kaitlyn Eddy

  Principal Engineer, Delivery, Device, and Connected Solutions (DDCS), Eli Lilly

Etkinlik sayfasında 23 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: Oncology & Immunology Innovation Partnering & Licensing Summit

• Adam Gilbert

  Science Partner, Flagship Pioneering

• Mike Jones

  Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical

• Jason Kantor

  Chief Business Officer, Nurix Therapeutics, Inc.

• Nikhil Mutyal

  Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

• Giovanni Spagnolli

  Co-Founder & Chief Technology Officer, Sibylla Biotech srl

• Dori Thomas-Karyat

  Chief Executive Officer, Synthis Therapeutics

Etkinlik sayfasında 50 konuşmacının tümünü gör